1. Home
  2. FSTR vs PRQR Comparison

FSTR vs PRQR Comparison

Compare FSTR & PRQR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo L.B. Foster Company

FSTR

L.B. Foster Company

HOLD

Current Price

$28.15

Market Cap

280.8M

Sector

Industrials

ML Signal

HOLD

Logo ProQR Therapeutics N.V.

PRQR

ProQR Therapeutics N.V.

HOLD

Current Price

$1.78

Market Cap

185.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FSTR
PRQR
Founded
1902
2012
Country
United States
Netherlands
Employees
N/A
166
Industry
Metal Fabrications
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
280.8M
185.4M
IPO Year
1995
2014

Fundamental Metrics

Financial Performance
Metric
FSTR
PRQR
Price
$28.15
$1.78
Analyst Decision
Hold
Strong Buy
Analyst Count
1
6
Target Price
$32.00
$7.67
AVG Volume (30 Days)
16.7K
280.8K
Earning Date
06-03-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.69
N/A
Revenue
$540,009,000.00
N/A
Revenue This Year
$5.44
$11.37
Revenue Next Year
$3.05
N/A
P/E Ratio
$40.78
N/A
Revenue Growth
1.74
N/A
52 Week Low
$17.16
$1.08
52 Week High
$32.63
$3.10

Technical Indicators

Market Signals
Indicator
FSTR
PRQR
Relative Strength Index (RSI) 41.95 55.26
Support Level $27.78 $1.65
Resistance Level $29.72 $1.80
Average True Range (ATR) 1.33 0.11
MACD -0.34 0.02
Stochastic Oscillator 29.06 57.00

Price Performance

Historical Comparison
FSTR
PRQR

About FSTR L.B. Foster Company

L.B. Foster Co is a technology solutions provider of products and services for the rail and infrastructure markets. The company has two reporting segments: Rail, Technologies, and Services (Rail); and Infrastructure Solutions (Infrastructure). Maximum revenue is generated from the Rail segment, which is comprised of several manufacturing and distribution businesses that provide products and services for freight and passenger railroads and industrial companies throughout the world. The Infrastructure segment offers engineered precast concrete solutions, as well as fabricated bridge, protective pipe coating, and pipe threading offerings across North America. Geographically, the company generates maximum revenue from the United States, followed by Canada, the UK, and other markets.

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

Share on Social Networks: